Home > Insider Trading > Filing (0000912282-23-000529)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1776738	Cannabist Co Holdings Inc.	CBSTF	Agricultural Production-Crops (100)	981488978

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1907623	Nicholas Vita	C/O The Cannabist Company Holdings Inc. 680 Fifth Avenue, 24Th Floor New York NY 10019	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2023-11-28	50,000	$0.34	21,127,075	No	4	S	Indirect	Held by Vita Holdings LLC
Common Shares	Disposition	2023-11-28	100,000	$0.33	21,027,075	No	4	S	Indirect	Held by Vita Holdings LLC
Common Shares	Disposition	2023-11-29	50,000	$0.34	20,977,075	No	4	S	Indirect	Held by Vita Holdings LLC
Common Shares	Disposition	2023-11-29	50,000	$0.34	20,927,075	No	4	S	Indirect	Held by Vita Holdings LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by Vita Holdings LLC
No	4	S	Indirect	Held by Vita Holdings LLC
No	4	S	Indirect	Held by Vita Holdings LLC
No	4	S	Indirect	Held by Vita Holdings LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	618,950	Direct

Footnotes

The sales price reported above was converted from the Canadian sales price of C$0.465 using an exchange rate of C$1.3581 = US$1.00.
The sales price reported above was converted from the Canadian sales price of C$0.45 using an exchange rate of C$1.3581 = US$1.00.
The sales price reported above was converted from the Canadian sales price of C$0.46 using an exchange rate of C$1.3590 = US$1.00.
The sales price reported above was converted from the Canadian sales price of C$0.465 using an exchange rate of C$1.3590 = US$1.00.
Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, educational and philanthropic purposes.